{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-care-constipation/prescribing-information/doses-of-laxatives/","result":{"pageContext":{"chapter":{"id":"d392c3a1-da3e-504d-9f7b-e0801274ef63","slug":"doses-of-laxatives","fullItemName":"Doses of laxatives","depth":2,"htmlHeader":"<!-- begin field dfba930d-0ae4-4ce2-804e-1b373d478085 --><h2>What doses of laxatives may be needed in palliative care?</h2><!-- end field dfba930d-0ae4-4ce2-804e-1b373d478085 -->","summary":"","htmlStringContent":"<!-- begin item dfc04e11-cb24-4fd7-8a92-e816b2847dd6 --><!-- begin field 3bbd3892-f5d0-4f98-842f-e95bfdd52995 --><p><strong>Table 4.</strong> Laxative doses that may be needed to manage constipation in palliative care.</p><table><thead><tr><th style=\"width: 189.219px;\" colspan=\"1\">Laxative</th><th style=\"width: 690.219px;\" colspan=\"1\">Licensed dose (adults)</th><th style=\"width: 349.219px;\" colspan=\"1\">Dose that may be needed in palliative care (off–label)</th></tr></thead><tbody><tr><td style=\"width: 189.219px;\" colspan=\"1\">Arachis (peanut) oil (retention enema)</td><td style=\"width: 690.219px;\" colspan=\"1\">1 enema (130 mL) at bedtime, as required</td><td style=\"width: 349.219px;\" colspan=\"1\">Use maximum licensed dose</td></tr><tr><td style=\"width: 189.219px;\" colspan=\"1\">Bisacodyl (tablets)</td><td style=\"width: 690.219px;\" colspan=\"1\">5–10 mg at night, increased if necessary to a maximum dose of 20 mg at night</td><td style=\"width: 349.219px;\" colspan=\"1\">20 mg three times a day</td></tr><tr><td style=\"width: 189.219px;\" colspan=\"1\">Bisacodyl (suppositories)</td><td style=\"width: 690.219px;\" colspan=\"1\">1 suppository (10 mg) in the morning</td><td style=\"width: 349.219px;\" colspan=\"1\">20 mg daily</td></tr><tr><td style=\"width: 189.219px;\" colspan=\"1\">Co-danthramer Strong (dantron/poloxamer 37.5/500 mg capsules or 75/1000 mg suspension)</td><td style=\"width: 690.219px;\" colspan=\"1\">1–2 capsules (or 5 mL only) at night</td><td style=\"width: 349.219px;\" colspan=\"1\">3 capsules three times a day (or 10 mL twice a day)</td></tr><tr><td style=\"width: 189.219px;\" colspan=\"1\">Co-danthrusate (dantron/docusate 50/60 mg capsules or suspension)</td><td style=\"width: 690.219px;\" colspan=\"1\">1–3 capsules (or 5–15 mL) at night</td><td style=\"width: 349.219px;\" colspan=\"1\">3 capsules twice a day (or 15 mL twice a day)</td></tr><tr><td style=\"width: 189.219px;\" colspan=\"1\">Docusate (capsules or solution)</td><td style=\"width: 690.219px;\" colspan=\"1\">Up to 500 mg per day in divided doses</td><td style=\"width: 349.219px;\" colspan=\"1\">200 mg three times a day</td></tr><tr><td style=\"width: 189.219px;\" colspan=\"1\">Docusate (Norgalax<sup>® </sup>micro-enema)</td><td style=\"width: 690.219px;\" colspan=\"1\">1 enema (120 mg in 10 g single-use disposable pack), as required</td><td style=\"width: 349.219px;\" colspan=\"1\">Use maximum licensed dose</td></tr><tr><td style=\"width: 189.219px;\" colspan=\"1\">Glycerol (suppositories)</td><td style=\"width: 690.219px;\" colspan=\"1\">1 suppository (4 g) moistened with water before use, as required</td><td style=\"width: 349.219px;\" colspan=\"1\">Use maximum licensed dose</td></tr><tr><td style=\"width: 189.219px;\" colspan=\"1\">Lactulose (syrup)</td><td style=\"width: 690.219px;\" colspan=\"1\">15 mL twice a day, adjusted according to response</td><td style=\"width: 349.219px;\" colspan=\"1\">Use maximum licensed dose</td></tr><tr><td style=\"width: 189.219px;\" colspan=\"1\">Macrogol 3350 + electrolytes (Movicol<sup>® </sup>sachets)</td><td style=\"width: 690.219px;\" colspan=\"1\">For constipation: 1–3 sachets per day, in divided doses, usually for up to 2 weeks; maintenance dose 1–2 sachets per day. For high faecal loading/impaction: 4 sachets on the first day, then increased in steps of 2 sachets daily to a maximum dose of 8 sachets per day. Contents of each sachet should be dissolved in 125 mL of water. After reconstitution the solution should be kept in a refrigerator and drunk within 6 hours. Limit to 2 sachets per hour (250 mL) in heart failure.</td><td style=\"width: 349.219px;\" colspan=\"1\">Use maximum licensed dose</td></tr><tr><td style=\"width: 189.219px;\" colspan=\"1\">Senna (tablets or syrup)</td><td style=\"width: 690.219px;\" colspan=\"1\">2–4  tablets (15–30 mg) at night or 10–20 mL, usually at bedtime</td><td style=\"width: 349.219px;\" colspan=\"1\">2–4 tablets (15–30 mg) three times a day</td></tr><tr><td style=\"width: 189.219px;\" colspan=\"1\">Sodium citrate (Micolette®, Micralax®, Relaxit® micro-enemas)</td><td style=\"width: 690.219px;\" colspan=\"1\">Micolette<sup>®</sup> 1–2 enemas (5–10 mL), as required Micralax<sup>®</sup> 1 enema (5 mL), as required Relaxit<sup>®</sup> 1 enema (5 mL), as required.</td><td style=\"width: 349.219px;\" colspan=\"1\">Use maximum licensed dose</td></tr><tr><td style=\"width: 189.219px;\" colspan=\"1\">Sodium picosulfate (capsules or syrup)</td><td style=\"width: 690.219px;\" colspan=\"1\">5–10 mg at night</td><td style=\"width: 349.219px;\" colspan=\"1\">30 mg per day</td></tr><tr><td style=\"width: 189.219px;\" colspan=\"1\">Sodium phosphate (Fleet® Ready-to-use enema, Phosphate enema BP Formula B)</td><td style=\"width: 690.219px;\" colspan=\"1\">Fleet<sup>®</sup> Ready-to-use enema 1 enema (118 mL), as required. Phosphate enema BP Formula B 1 enema (128 mL), as required.</td><td style=\"width: 349.219px;\" colspan=\"1\">Use maximum licensed dose</td></tr><tr><td style=\"width: 1256.22px;\" colspan=\"3\"><p><strong>Data from:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-constipation/references/\">Regnard, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-constipation/references/\">Twycross, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-constipation/references/\">BNF 72, 2016</a>]</p></td></tr></tbody></table><p><strong>Table 4</strong>. Dose schedule for dantron-containing laxatives*<sup>†</sup></p><table><thead><tr><th colspan=\"1\"> </th><th colspan=\"1\">Co-danthramer strong capsules</th><th colspan=\"1\">Co-danthramer strong suspension</th><th colspan=\"1\">Co-danthrusate capsules</th><th colspan=\"1\">Co-danthrusate suspension</th></tr></thead><tbody><tr><td colspan=\"1\">Dantron content</td><td colspan=\"1\">37.5 mg/capsule</td><td colspan=\"1\">75 mg/capsule</td><td colspan=\"1\">50 mg/capsule</td><td colspan=\"1\">50 mg/capsule</td></tr><tr><td colspan=\"1\">Start with (prophylactic):</td><td colspan=\"1\">1 at bedtime</td><td colspan=\"1\">2.5 mL at bedtime</td><td colspan=\"1\">1 at bedtime</td><td colspan=\"1\">5 mL at bedtime</td></tr><tr><td colspan=\"1\">Start with (if constipated):</td><td colspan=\"1\">2 at bedtime</td><td colspan=\"1\">5 mL at bedtime</td><td colspan=\"1\">2 at bedtime</td><td colspan=\"1\">10 mL at bedtime</td></tr><tr><td colspan=\"1\">If necessary, adjust every 2–3 days up to:</td><td colspan=\"1\">3 three times a day</td><td colspan=\"1\">10 mL twice a day or 20 mL at bedtime</td><td colspan=\"1\">3 twice a day</td><td colspan=\"1\">15 mL twice a day</td></tr><tr><td colspan=\"1\">Total daily dose</td><td colspan=\"1\">337.5 mg</td><td colspan=\"1\">300 mg</td><td colspan=\"1\">300 mg</td><td colspan=\"1\">300 mg</td></tr><tr><td colspan=\"5\">* because dantron has been linked with liver and bowel tumours in rodents, dantron-containing laxatives are licensed for use only in the 'terminally ill'. † in people with urinary or faecal incontinence, dantron-containing laxatives are best avoided because of the risk of a contact skin burn in the perineum and surrounding areas</td></tr><tr><td colspan=\"5\"><strong>Data from:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-constipation/references/\">Twycross, 2014</a>]</td></tr></tbody></table><!-- end field 3bbd3892-f5d0-4f98-842f-e95bfdd52995 --><!-- end item dfc04e11-cb24-4fd7-8a92-e816b2847dd6 -->","topic":{"id":"4a368333-0a3d-5f76-906b-e2268205df04","topicId":"5f5e551e-9e71-40c0-a276-1d902ad4a4c1","topicName":"Palliative care - constipation","slug":"palliative-care-constipation","lastRevised":"Last revised in October 2016","chapters":[{"id":"0bd21138-1475-5387-a62f-abf3cd882967","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"46765bba-ab36-575c-9b95-19157184302c","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"49b7dbfb-d2a6-52ac-a7b1-078151eb649e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"8b3a00ff-7217-5c77-8f1f-b92183f39816","slug":"changes","fullItemName":"Changes"},{"id":"3e25df9e-81df-595b-99a9-ed6b07a209ca","slug":"update","fullItemName":"Update"}]},{"id":"dd8c5383-f07d-5073-8cef-a8d120fa15e7","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"7fe62805-a606-500e-8c43-84cfa7064b28","slug":"goals","fullItemName":"Goals"},{"id":"a0f9f25e-78f6-5a5f-bee4-655dbe3aebf9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"03ef715c-b493-5fa9-865d-17aa2bad4d7a","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"2ff41646-ad03-5f09-82f4-3918ca4c398d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"bae2bd58-75ae-5ee3-a4fe-b91d6d680706","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d90009d9-0a9b-594b-90dd-4b279a58b75d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a460fbe5-d503-5e5e-b282-d915ef4cb4dc","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"e89cc0d6-3772-50be-bf89-d5d1ffd233a3","slug":"definition","fullItemName":"Definition"},{"id":"2760d124-c1d6-59c8-9105-78a875242beb","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0ea3e359-97ed-57ae-9e85-9efea8886a68","slug":"causes","fullItemName":"Causes"},{"id":"a492cd7e-47f4-5b23-8afe-9a2964aa578a","slug":"complications","fullItemName":"Complications"}]},{"id":"cdefb1ca-fcd7-5b0d-af18-7495a1d2d8a0","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"4ad1ef11-537f-51f5-948a-7986d9dd73c1","slug":"diagnosis","fullItemName":"Diagnosis"}]},{"id":"a008cacc-31cd-521c-a4a0-dd3390cb3e8b","fullItemName":"Management","slug":"management","subChapters":[{"id":"c69c7c37-73c5-59b7-88d3-d6f65fc9084a","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"4c850fd1-1555-530c-ba9d-5b7a9376cd8e","slug":"management","fullItemName":"Scenario: Management"},{"id":"0d35e849-a35d-57f8-95bc-4451c7860318","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"}]},{"id":"0dc337fa-247c-5c9a-b131-ee82e1de76ed","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"3803954e-da2d-53d0-bbde-a4c0f1f1814a","slug":"how-laxatives-work","fullItemName":"How laxatives work"},{"id":"f4ac067a-0b08-5d71-bc90-999692229422","slug":"choice-of-laxative","fullItemName":"Choice of laxative"},{"id":"1457f2af-4ac9-5136-81f2-f393d1e96ccc","slug":"time-to-wait-for-laxative-effect","fullItemName":"Time to wait for laxative effect"},{"id":"d392c3a1-da3e-504d-9f7b-e0801274ef63","slug":"doses-of-laxatives","fullItemName":"Doses of laxatives"},{"id":"22032104-4871-51eb-b4bd-e420cbabba2f","slug":"adverse-effects-of-oral-laxatives","fullItemName":"Adverse effects of oral laxatives"},{"id":"11d6141d-5f59-54c4-bb8c-4a14536ccec9","slug":"preventing-adverse-effects-of-rectal-laxatives","fullItemName":"Preventing adverse effects of rectal laxatives"}]},{"id":"2cd20dab-1981-5f4f-9ccd-6c83eddd1eeb","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[{"id":"1766cdb0-0d5d-5eb3-acae-8ab4bf1a8317","slug":"laxatives-for-constipation-in-palliative-care","fullItemName":"Laxatives for constipation in palliative care"}]},{"id":"9e865fed-6388-5fca-af20-09dd4d49d221","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"aa5ff9dc-c749-5e99-9fa6-b79f92aa3a52","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"ea75ad39-b519-5f0b-a41a-a81e037861c1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"21da17fa-8ccf-50d1-9777-e39a0edb012d","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8ae0a4d3-9d0f-5829-9762-63a32cc46284","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"c21690ba-8fc9-5f35-a380-4a8ad1a0ee8a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1461531f-ee19-5a21-ab10-c5914590d6c9","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"0dc337fa-247c-5c9a-b131-ee82e1de76ed","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}